Momentum Research, Inc.
The company appears to be involved in research related to heart failure, with a focus on drug development, clinical trials, and treatment strategies for acute and chronic heart failure. They analyze recent studies, clinical trial data, and explore new therapies and biomarkers to improve patient outcomes.
Industries
Nr. of Employees
small (1-50)
Momentum Research, Inc.
Services
Consulting on trial architecture from early-phase proof-of-activity to Phase III, including endpoint and population selection.
Support for evaluation, clinical use-case definition, and validation of biomarkers to enable personalized approaches and trial enrichment.
Assessment of regional variation and site capabilities to optimize global trial execution and mitigate operational risks.
Design and application of statistical methods for multiple endpoints, global endpoint approaches, and interpretation of trial efficacy data.
Production of literature reviews, position papers, and expert summaries to guide research priorities and trial design decisions.
Consulting on trial architecture from early-phase proof-of-activity to Phase III, including endpoint and population selection.
Support for evaluation, clinical use-case definition, and validation of biomarkers to enable personalized approaches and trial enrichment.
Assessment of regional variation and site capabilities to optimize global trial execution and mitigate operational risks.
Design and application of statistical methods for multiple endpoints, global endpoint approaches, and interpretation of trial efficacy data.
Production of literature reviews, position papers, and expert summaries to guide research priorities and trial design decisions.
Expertise Areas
- Acute heart failure clinical trial design
- Clinical endpoint development and regulatory strategy
- Biomarker development and validation
- Patient phenotyping and targeted intervention selection
Key Technologies
- Clinical trial methodology
- Biomarker assay development and validation
- Hemodynamic monitoring techniques
- Composite/global endpoint statistical methods
News & Updates
Discussion on the focus of new drug development in heart failure, especially for patients discharged after an acute heart failure admission, and lessons learned from recent studies.
Analysis of the nature of acute heart failure and its implications for therapy.
Discussion on the role of inflammation and corticosteroids in acute heart failure management.
Focus on the critical period after acute heart failure admission for targeted therapy.
Comparison of trial methodologies between heart failure and oncology.
Study on how regional differences affect outcomes of antidiabetic medications in cardiovascular trials.
Discussion on the focus of new drug development in heart failure, especially for patients discharged after an acute heart failure admission, and lessons learned from recent studies.
Analysis of the nature of acute heart failure and its implications for therapy.
Discussion on the role of inflammation and corticosteroids in acute heart failure management.
Focus on the critical period after acute heart failure admission for targeted therapy.
Comparison of trial methodologies between heart failure and oncology.
Study on how regional differences affect outcomes of antidiabetic medications in cardiovascular trials.